Cargando…
Clinically significant chronic liver disease in people with Type 2 diabetes: the Edinburgh Type 2 Diabetes Study
Background: Type 2 diabetes is an independent risk factor for chronic liver disease, however disease burden estimates and knowledge of prognostic indicators are lacking in community populations. Aims: To describe the prevalence and incidence of clinically significant chronic liver disease amongst co...
Autores principales: | Morling, J.R., Fallowfield, J.A., Guha, I.N., Williamson, R.M., Ali, M., Glancy, S., Strachan, M.W.J., Price, J.F. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4815616/ https://www.ncbi.nlm.nih.gov/pubmed/26454513 http://dx.doi.org/10.1093/qjmed/hcv191 |
Ejemplares similares
-
γ-Glutamyltransferase, but not markers of hepatic fibrosis, is associated with cardiovascular disease in older people with type 2 diabetes mellitus: the Edinburgh Type 2 Diabetes Study
por: Morling, Joanne R., et al.
Publicado: (2015) -
Addition of hyaluronic acid to the FIB‐4 liver fibrosis score improves prediction of incident cirrhosis and hepatocellular carcinoma in type 2 diabetes: The Edinburgh Type 2 Diabetes Study
por: Grecian, Sheila M., et al.
Publicado: (2021) -
The Edinburgh Type 2 Diabetes Study: study protocol
por: Price, Jackie F, et al.
Publicado: (2008) -
Prevalence of and Risk Factors for Hepatic Steatosis and Nonalcoholic Fatty Liver Disease in People With Type 2 Diabetes: the Edinburgh Type 2 Diabetes Study
por: Williamson, Rachel M., et al.
Publicado: (2011) -
Clinical and Subclinical Macrovascular Disease as Predictors of Cognitive Decline in Older Patients With Type 2 Diabetes: The Edinburgh Type 2 Diabetes Study
por: Feinkohl, Insa, et al.
Publicado: (2013)